Evidence map›Paper›PMID 17893688›Full record

ReviewNature clinical practice. Endocrinology & metabolism2007

The metabolic syndrome in women.

Rhonda Bentley-Lewis, Katherine Koruda, Ellen W Seely

Registry-linked trialAbstract readReview
In one paragraph

Review in Nature clinical practice. Endocrinology & metabolism, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05387174 (Nursing Intervention in Two Risk Factors of the Metabolic Syndrome, Abdominal Obesity and Arterial Hypertension, and Quality of Life in the Climacteric Period), which is not on this map. Cited by 71 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 5 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05387174 nacompletednot on this mapstarted 2021, after this paper: background citation

Nursing Intervention in Two Risk Factors of the Metabolic Syndrome, Abdominal Obesity and Arterial Hypertension, and Quality of Life in the Climacteric Period

TypeinterventionalSponsorUniversidad de ConcepcionRan2021 to 2021Enrolled80ConditionsObesity, Abdominal, Hypertension, Quality of Life, MenopauseArms: Nursing intervention in two risk factors of the Metabolic Syndrome, abdominal obesity and arterial hypertension and quality of life in the climacteric period.
3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 5 syntheses or guidelines pooled it, 149 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. PCOS and Obesity: Contraception Challenges.Open access journal of contraception · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Rhonda Bentley-LewisHarvard Medical School, Brigham and Women's Hospital, Division of Endocrinology, Diabetes, and Hypertension, Boston, MA 02115, USA. rbentleylewis@partners.org
Katherine Koruda
Ellen W Seely
Brigham and Women's Hospital · USHarvard University · US

Funding

Mechanisms Underlying Sodium Intake Mediated Vascular FunctionK23RR023333 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BENTLEY-LEWIS, RHONDA · 2007 to 2011
$813k
NCRR NIH HHS K23 RR023333NIMHD NIH HHS L32 MD001077
6 · The paper itself

Abstract

The metabolic syndrome is estimated to be present in 47 million US residents with a similar age-adjusted prevalence in men (24%) and women (23%). The consideration of various metabolic risk factors as a single entity in the metabolic syndrome provides clinicians with a tool by which they can identify a population at increased risk for type 2 diabetes mellitus and increased cardiovascular morbidity and mortality. Cardiovascular disease is the leading cause of mortality in women in the US. To reduce the risk of cardiovascular disease, efforts have focused on modifying the metabolic risk factors that constitute the metabolic syndrome: abdominal obesity, dyslipidemia, glucose intolerance, and hypertension. In addition, because of several circumstances specific to women, including pregnancy, polycystic ovary syndrome, oral contraceptive therapy use, and menopause, there are special considerations regarding risk factor identification, modification, and clinical management. This article provides a review of diagnostic and therapeutic issues that clinicians should consider when caring for women at risk for developing or diagnosed with the metabolic syndrome.

Indexed as

Cardiovascular DiseasesFemaleHumansMaleMetabolic SyndromeRisk Factors

Identifiers

PMID17893688
PMCPMC4428566
OpenAlexW2152138503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.